In murine breast cancer models, DCs stimulated with leptin (particularly when combined with LPS) reduced tumor-promoting gene expression, including matrix metalloproteinase 9 (MMP9), CCL5, and vascular endothelial growth factor (VEGF), and decreased IL-6 secretion [122]. The gene discussed is LEP; the disease is neoplasm.